Companies / Altis Labs
Altis Labs
Altis Labs is a health and biotech AI company based in Toronto, Ontario. It had raised US$31M as of November 2026, most recently a US$25M Series A in September 2026 led by OrbiMed and Qiming Venture Partners USA.
AI endpoints for oncology trials; IPRO model predicts survival from routine radiology scans (Nota platform).
altislabs.com- Founded
- 2019
- Category
- Health/
Bio AI - Status
- Active
- Disclosed raised
- US$31M
Funding history
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series A | Sep 17, 2026 | US$25M | OrbiMed and Qiming Venture Partners USA (co-leads); Innovation Endeavors, Benchstrength, Fusion Fund, Lumira Ventures. Co-led by OrbiMed and Qiming Venture Partners USA; Innovation Endeavors, Benchstrength, Fusion Fund and Lumira Ventures (via the Cancer Breakthrough Fund) participated. Business Wire release dated Sep 17, 2026 from Toronto. |
| Seed | Jun 22, 2023 | US$6M | Benchstrength and Debiopharm Innovation Fund (co-leads). US$6M (C$7.9M) seed co-led by Benchstrength and the Debiopharm Innovation Fund with angels. Precedes the 2026 Series A. |
Founders
- Felix Baldauf-Lenschen, Co-founder/CEO.
- Sally Daub, Co-founder/President.
In the newsletter
Sources
Data as of November 10, 2026.